Clinical Trial

Understanding How Ketamine Brings About Rapid Improvement in OCD

Study acronym: MKET
Completed Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of this study is to understand how ketamine brings about rapid improvement in Obsessive-Compulsive Disorder (OCD) symptoms.
Protocol Amendment History 3 changes
critical Trial completed 2026-08-14
notable Primary completion moved earlier: 2026-06 -> 2021-06-20 2026-08-14
minor Completion moved earlier: 2026-06 -> 2021-06-28 2026-08-14
Trial Details
NCT Number NCT02624596
Lead Sponsor Stanford University
Collaborators: University of Connecticut
Conditions Obsessive-Compulsive Disorder
Enrollment 120 participants
Start Date 2016-08-16
Primary Completion 2021-06-20 (estimated)
Study Completion 2021-06-28 (estimated)
Updated on ClinicalTrials.gov 2026-08-13